BioScience Health Innovations, Inc. financial data

Symbol
BHIC on OTC
Location
Salt Lake City, UT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 27 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 15.65 % -50.3%
Return On Equity 64.09 % +1.8%
Return On Assets 55.41 % +2.1%
Operating Margin 18.74 % +6.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10,979,055 shares -73.9%
Common Stock, Shares, Outstanding 10,979,055 shares -73.9%
Entity Public Float 41,596,221 USD
Common Stock, Value, Issued 1,098 USD -73.9%
Weighted Average Number of Shares Outstanding, Basic 10,979,055 shares +4.8%
Weighted Average Number of Shares Outstanding, Diluted 10,979,055 shares +0.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4,726,182 USD +2.1%
Research and Development Expense 37,540 USD +45.6%
Operating Income (Loss) 885,677 USD +21.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 885,677 USD +21.9%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1,139,423 USD +2.4%
Accounts Receivable, after Allowance for Credit Loss, Current 63,212 USD +98.1%
Inventory, Net 757,500 USD +16.9%
Assets, Current 1,994,999 USD +3.9%
Intangible Assets, Net (Excluding Goodwill) 72,101 USD +9.2%
Assets 2,067,100 USD +4%
Accounts Payable, Current 10,165 USD +20.3%
Accrued Liabilities, Current 6,686 USD +1.7%
Liabilities 356,140 USD +6.8%
Retained Earnings (Accumulated Deficit) 534,637 USD
Stockholders' Equity Attributable to Parent 1,710,960 USD +3.6%
Liabilities and Equity 2,067,100 USD +4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 328,309 USD
Net Cash Provided by (Used in) Financing Activities 67,516 USD -44.5%
Net Cash Provided by (Used in) Investing Activities -30,000 USD
Common Stock, Shares Authorized 250,000,000 shares +2.3%
Common Stock, Shares, Issued 10,979,055 shares -73.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1,139,423 USD +2.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 48,977 USD -33%
Deferred Tax Assets, Operating Loss Carryforwards 47,419 USD -5.4%
Preferred Stock, Shares Issued 140,000 shares 0%
Preferred Stock, Shares Authorized 140,000 shares 0%
Additional Paid in Capital 1,175,211 USD +63.9%
Preferred Stock, Shares Outstanding 140,000 shares 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%